Thrombocytopenia induced by nicotinamide in hemodialysis patients

被引：26

作者：

Rottembourg, JB ^{[1
]}

Launay-Vacher, V ^{[1
]}

Massard, J ^{[1
]}

机构：

[1] Hop Pitie, Dept Nephrol, F-75013 Paris, France

来源：

KIDNEY INTERNATIONAL | 2005年 / 68卷 / 06期

关键词：

D O I：

10.1111/j.1523-1755.2005.00583_8.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2911 / 2912

页数：2

共 5 条

[1] Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure [J].

Chertow, GM ;

Burke, SK ;

Lazarus, JM ;

Stenzel, KH ;

Wombolt, D ;

Goldberg, D ;

Bonventre, JV ;

Slatopolsky, E .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (01) :66-71

[2] Safety of high dose nicotinamide: a review [J].

Knip, M ;

Douek, IF ;

Moore, WPT ;

Gillmor, HA ;

McLean, AEM ;

Bingley, PJ ;

Gale, EAM .

DIABETOLOGIA, 2000, 43 (11) :1337-1345

[3] NICOTINIC ACID-INDUCED TOXICITY ASSOCIATED WITH CYTOPENIA AND DECREASED LEVELS OF THYROXINE-BINDING GLOBULIN [J].

OBRIEN, T ;

SILVERBERG, JD ;

NGUYEN, TT .

MAYO CLINIC PROCEEDINGS, 1992, 67 (05) :465-468

[4] Nicotinamide suppresses hyperphosphatemia in hemodialysis patients [J].

Takahashi, Y ;

Tanaka, A ;

Nakamura, T ;

Fukuwatari, T ;

Shibata, K ;

Shimada, N ;

Ebihara, I ;

Koide, H .

KIDNEY INTERNATIONAL, 2004, 65 (03) :1099-1104

[5]

Wakasugi H, 2000, NEPHRON, V86, P97

← 1 →